GSK agrees to acquire Aiolos Bio for $1.4 billion

GlaxoSmithKline plc (GSK) announced Tuesday that it reached an agreement to acquire Aiolos Bio, Inc., a clinical-stage biopharmaceutical company, for an initial payment of $1 billion and up to an addi…